NPC-1C: Phase I started

Neogenix began an open-label, dose-escalation Phase I

Read the full 72 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE